DB-1310, a HER3-targeting antibody-drug conjugate, has synergistic anti-tumor activity with trastuzumab in HER2- and HER3-expressing breast cancer

Saved in:
Bibliographic Details
Main Authors: Xi Li, Liwen Liang, Zhongyuan Zhu, Haiqing Hua, Yang Qiu
Format: Article
Language:English
Published: China Anti-Cancer Association 2025-03-01
Series:Cancer Biology & Medicine
Online Access:https://www.cancerbiomed.org/content/22/3/231
Tags: Add Tag
No Tags, Be the first to tag this record!